Evidence map›Paper›PMID 35545617›Full record

SynthesisTranslational psychiatry2022

Is it possible to stage schizophrenia? A systematic review.

Clara Martínez-Cao, Lorena de la Fuente-Tomás, Ainoa García-Fernández, Leticia González-Blanco, Pilar A Sáiz, María Paz Garcia-Portilla, Julio Bobes

Abstract readSystematic Review
In one paragraph

Synthesis in Translational psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspective.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Review
  4. Transdiagnostic Clinical Staging in Youth Mental Health: A primer for clinical practice.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2025
    Review
  5. Article
  6. PsiOvi Staging Model for Schizophrenia (PsiOvi SMS): A New Internet Tool for Staging Patients with Schizophrenia.European psychiatry : the journal of the Association of European Psychiatrists · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clara Martínez-CaoDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0002-3803-9301
Lorena de la Fuente-TomásDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0001-8220-5007
Ainoa García-FernándezDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0002-4874-0353
Leticia González-BlancoDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0001-6238-4773
Pilar A SáizDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0002-5705-4523
María Paz Garcia-PortillaDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain. albert@uniovi.es.ORCID http://orcid.org/0000-0003-3643-1622
Julio BobesDepartment of Psychiatry, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0003-2187-4033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA staging model is a clinical tool used to define the development of a disease over time. In schizophrenia, authors have proposed different theoretical staging models of increasing complexity. Therefore, the aims of our study were to provide an updated and critical view of the proposed clinical staging models for schizophrenia and to review the empirical data that support them.

methodsSystematic literature review following PRISMA guidelines. From the PubMed database and backward reference search, a total of 141 records were retrieved, but only 20 were selected according to the inclusion criteria: (a) available in English; (b) participants with schizophrenia ≥ 18 years; and (c) theoretical and empirical research studies intended to develop, validate, and/or improve staging models of schizophrenia.

resultsDifferent clinical staging models for schizophrenia were identified, information about the proposed stages was tabulated and presented in the Results section (Tables 1, 2). Most of which include neuroimaging, functioning, and psychopathology, but only two models add objective biomarkers and none include patient point of view. However, few models have been psychometrically tested or used small samples and thus have been validated only partially. In addition, five studies proposed therapeutic interventions according to the stage of the disorder from a theoretical point of view. DISCUSSION: In conclusion, it is possible to stage schizophrenia, but the models developed have several limitations. Empirical validation and inclusion of more specific biomarkers and measures of other life areas affected by schizophrenia could help in the development of more valid models.

Indexed as

SchizophreniaHumans

Identifiers

PMID35545617
PMCPMC9095725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.